首页> 外国专利> Naproxen and naproxen sodium tablets CONTROLLED drug release

Naproxen and naproxen sodium tablets CONTROLLED drug release

机译:萘普生和萘普生钠片控制药物释放

摘要

A controlled release tablet for once-daily oral administration of about 500-1200 mg of naproxen or naproxen sodium, said tablet being a homogeneous matrix comprising about 4-9 weight percent of hydroxypropylmethylcellulose having a number average molecular weight in the range of from about 80,000 to about 130,000, about 81-96 weight percent naproxen or naproxen sodium, 0.1 to about 2 weight percent of a pharmacetucailly acceptable lubricating agent, and 0 to about 8 weight percent of other pharmaceutically acceptable excipients.
机译:每天一次口服约500-1200 mg萘普生或萘普生钠的控释片剂,所述片剂是均质基质,包含约4-9重量%的羟丙基甲基纤维素,其数均分子量为约80,000至约130,000,约81-96重量百分比的萘普生或萘普生钠,0.1至约2重量百分比的药学可接受的润滑剂,和0至约8重量百分比的其他药学可接受的赋形剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号